Table 2.
Characteristics of hospitalized coronavirus disease-2019-positive patients in the study
| Characteristics | Observed values (n=48) Mean±SD or n (%) |
|---|---|
| Complications during hospital stay* | |
| ARDS | 7 (14.5) |
| Pneumothorax | 1 (2.1) |
| Arrhythmia | 2 (4.2) |
| Myopericarditis | 1 (2.1) |
| Superadded infections | 7 (14.5) |
| Elevated liver enzymes | 4 (8.3) |
| Hypoglycemia | 3 (6.2) |
| Acute kidney injury | 3 (6.2) |
| Seizure | 2 (4.2) |
| Investigations** | |
| Hemoglobin (g/dL) | 13.0±3.2 |
| Neutrophil: lymphocyte ratio | 1.5±1.3 |
| Platelet count (lakh/mm3) | 2.6±1.1 |
| C-reactive protein (mg/dL) | 6.0±3.5 |
| Serum creatinine (mg/dL) | 0.5±0.5 |
| Need for medications related to COVID-19* | |
| Corticosteroids | 12 (25) |
| Remdesivir | 6 (12.5) |
| Heparin | 14 (29.2) |
| Inotrope/ventilation requirement* | |
| Need for invasive ventilation | 13 (27.1) |
| Need for noninvasive ventilation | 6 (12.5) |
| Shock | 11 (22.9) |
| Heart failure | 12 (25) |
| Procedures during index hospitalization* | |
| Emergency interventions | 3 (6.2) |
| Emergency surgery | 2 (4.2) |
| Surgery after recovery from COVID-19 | 17 (35.4) |
| Death* | 13 (27.1) |
*Percentage of number of hospitalized patients, **Performed in limited number of patients. ARDS: Acute respiratory distress syndrome, COVID-19: Coronavirus disease-2019, SD: Standard deviation